Clinical Trial Update: Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update comparing the CDOP chemotherapy regimen alone versus CDOP combined with chidamide in de novo Peripheral T-Cell Lymphoma to evaluat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• CDOP
• Chidamide (chidamide)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Peripheral T Cell Lymphoma | Phase 3 | Status: UNKNOWN